1. Home
  2. MYNZ vs ENG Comparison

MYNZ vs ENG Comparison

Compare MYNZ & ENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • ENG
  • Stock Information
  • Founded
  • MYNZ 2021
  • ENG 1985
  • Country
  • MYNZ Germany
  • ENG United States
  • Employees
  • MYNZ N/A
  • ENG N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • ENG Military/Government/Technical
  • Sector
  • MYNZ Health Care
  • ENG Consumer Discretionary
  • Exchange
  • MYNZ Nasdaq
  • ENG Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • ENG 7.2M
  • IPO Year
  • MYNZ 2021
  • ENG 1998
  • Fundamental
  • Price
  • MYNZ $0.48
  • ENG $1.43
  • Analyst Decision
  • MYNZ Buy
  • ENG
  • Analyst Count
  • MYNZ 2
  • ENG 0
  • Target Price
  • MYNZ $3.00
  • ENG N/A
  • AVG Volume (30 Days)
  • MYNZ 1.3M
  • ENG 9.1K
  • Earning Date
  • MYNZ 08-13-2024
  • ENG 08-08-2024
  • Dividend Yield
  • MYNZ N/A
  • ENG N/A
  • EPS Growth
  • MYNZ N/A
  • ENG N/A
  • EPS
  • MYNZ N/A
  • ENG N/A
  • Revenue
  • MYNZ $895,479.00
  • ENG $32,371,000.00
  • Revenue This Year
  • MYNZ $67.40
  • ENG $694.29
  • Revenue Next Year
  • MYNZ $191.13
  • ENG N/A
  • P/E Ratio
  • MYNZ N/A
  • ENG N/A
  • Revenue Growth
  • MYNZ 69.00
  • ENG N/A
  • 52 Week Low
  • MYNZ $0.32
  • ENG $1.01
  • 52 Week High
  • MYNZ $4.90
  • ENG $3.44
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 47.27
  • ENG 49.78
  • Support Level
  • MYNZ $0.39
  • ENG $1.29
  • Resistance Level
  • MYNZ $0.56
  • ENG $1.45
  • Average True Range (ATR)
  • MYNZ 0.09
  • ENG 0.10
  • MACD
  • MYNZ 0.02
  • ENG 0.02
  • Stochastic Oscillator
  • MYNZ 66.45
  • ENG 70.83

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About ENG ENGlobal Corporation

ENGlobal Corp engages in providing engineering and professional services to the energy industry. The company operates through two segments Commercial and Government Services. The Commercial segment derives revenue on contracts from time-and-material fees charged for professional and technical services. The Government segment provides services related to the design, integration and implementation of process distributed control and analyzer systems, advanced automated data gathering systems, information technology and the maintenance of these systems to the U.S. Government globally.

Share on Social Networks: